Pages
Products

DARC


Official Full Name
Duffy blood group, chemokine receptor
Synonyms
DARC; Duffy blood group, chemokine receptor; Duffy blood group , FY; Duffy antigen/chemokine receptor; CCBP1; CD234; Dfy; GPD; glycoprotein D; Fy glycoprotein; Duffy blood group antigen; plasmodium vivax receptor; FY; GpFy; WBCQ1

Cat.No. Product Name Price
SHH263545 shRNA set against Rat CHRNA2 (NM_133420.1) Inquiry
SHG177247 shRNA set against Rat Chrna2(NM_133420.1) Inquiry
SHG177265 shRNA set against Mouse Chrna2(NM_144803.2) Inquiry
SHG177577 shRNA set against Human CHRNA2(NM_000742.3) Inquiry
SHH263537 shRNA set against Human CHRNA2 (NM_000742.3) Inquiry
SHH263541 shRNA set against Mouse CHRNA2 (NM_144803.2) Inquiry
SHH274593 shRNA set against Human DARC (NM_002036.3) Inquiry
SHW005321 shRNA set against Chicken CHRNA2 (NM_204815) Inquiry
Cat.No. Product Name Price
OE-PNDC000291 Human CHRNA2 Nanodisc Inquiry
Cat.No. Product Name Price
CDFR014019 Rat Chrna2 cDNA Clone(NM_133420.1) Inquiry
MiUTR1H-02142 CHRNA2 miRNA 3'UTR clone Inquiry
MiUTR1M-03019 CHRNA2 miRNA 3'UTR clone Inquiry
MiUTR1R-00981 CHRNA2 miRNA 3'UTR clone Inquiry
MiUTR3H-12997 DARC miRNA 3'UTR clone Inquiry
MiUTR3H-12998 DARC miRNA 3'UTR clone Inquiry
CDCB166796 Chicken CHRNA2 ORF Clone (NM_204815) Inquiry
CDCB187624 Rabbit CHRNA2 ORF clone (XM_002709452.2) Inquiry
CDCR047020 Human CHRNA2 ORF clone (NM_000742.3) Inquiry
CDCR381074 Rat Chrna2 ORF Clone(NM_133420.1) Inquiry
CDCR383130 Mouse Chrna2 ORF Clone(NM_144803.2) Inquiry
CDCS407721 Human DARC ORF Clone (BC017817) Inquiry

Detailed Information

The Duffy blood group antigen, also known as Duffy antigen receptor for chemokines (DARC), is a glycoprotein receptor that plays a significant role in human immunity and disease. Named after its discovery by the hematologist Terence Hamblin in 1950, the Duffy antigen was initially identified as a blood group system. Individuals can be classified as Duffy positive (Fy^a/b^+) or Duffy negative (Fy^a/b^-), based on the presence or absence of the Duffy antigen on red blood cells.

DARC: A Versatile Chemokine Receptor

Duffy antigen receptor for chemokines (DARC) is known for its unique ability to bind a wide range of chemokines. Chemokines are small signaling proteins secreted by cells to attract immune cells to sites of infection, inflammation, or tissue damage.

The broad binding specificity of DARC allows it to interact with various chemokines, including those involved in immune responses, inflammation, and tissue repair. Through these interactions, DARC influences the movement and positioning of immune cells within the body. By binding and sequestering chemokines, DARC modulates the immune response, controlling the recruitment and activity of immune cells in different tissues and organs. This function not only contributes to normal immune responses but also has implications in various diseases, including inflammatory disorders and infections.

Beyond its blood group function, DARC is primarily recognized as a chemokine receptor, participating in immune responses and inflammation. DARC binds various chemokines, which are small signaling proteins involved in immune cell trafficking and activation. Through its interactions with chemokines, DARC influences the migration and localization of immune cells, playing a crucial role in the immune defense against pathogens and in inflammatory processes.

DARC and Malaria: Unraveling the Parasitic Connection

Duffy Antigen Receptor for Chemokines (DARC) plays a pivotal role in the context of malaria, a life-threatening infectious disease caused by Plasmodium parasites. Plasmodium vivax, a parasite causing malaria, relies on DARC for red blood cell invasion, and the absence of DARC in Duffy-negative individuals provides resistance against P. vivax malaria. Specifically, DARC serves as a receptor on red blood cells, facilitating the invasion of Plasmodium vivax, one of the malaria-causing parasites. Individuals lacking DARC expression, known as Duffy-negative individuals, exhibit a natural resistance to P. vivax malaria. The absence of DARC on the surface of red blood cells prevents the parasite from entering these cells, providing a unique genetic defense mechanism against this particular strain of malaria.

Interestingly, DARC has a unique feature; it lacks the G-protein signaling domain commonly found in other chemokine receptors. Due to this absence, DARC does not initiate typical intracellular signaling pathways upon chemokine binding. Instead, it acts as a "silent" receptor, sequestering chemokines and regulating their availability in the bloodstream. This sequestration function of DARC has implications in various diseases, including malaria.

References:

  1. Łukasik, Ewa, and Kazimiera Waśniowska. "Antygeny układu grupowego Duffy: budowa, właściwości serologiczne i funkcja" [Duffy blood group antigens: structure, serological properties and function]. Postepy higieny i medycyny doswiadczalnej (Online) vol. 70 143-61. 4 Mar. 2016, doi:10.5604/17322693.1196360
  2. Halawani, Amr J et al. "Prevalence of Duffy Blood Group Antigens and Phenotypes among Saudi Blood Donors in Southwestern Saudi Arabia." Clinical laboratory vol. 67,1 (2021): 10.7754/Clin.Lab.2020.200505. doi:10.7754/Clin.Lab.2020.200505
Quick Inquiry